Central serous chorioretinopathy associated with administration of sympathomimetic agents

Abstract

Purpose: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity.

Design: Observational case series.

Methods: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties.

Results: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication.

Conclusions: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.